Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity

Conventional type 1 dendritic cells (cDC1s) capture antigens in peripheral tissues and migrate to draining lymph nodes (dLNs) to prime antigen-specific CD8<sup>+</sup> T cells. How tumor antigens are processed to activate CD8<sup>+</sup> T cell immunity is not well understood. In this work, we show that Ms4a7 is up-regulated in cDC1s after tumor antigen uptake or exposure to exogenous stimuli and is required for their cross-priming ability. Although <i>Ms4a7</i><sup>-/-</sup> mice showed normal cDC1 development and turnover, they failed to prime antigen-specific CD8<sup>+</sup> T cells following infection or tumor development. In human cancers, <i>MS4A7</i> was expressed in a subset of cDC1s, preferentially enriched in dLNs, and correlated with patient survival. Our findings suggest a critical role for Ms4a7 in cDC1-mediated cross-presentation and antitumor CD8<sup>+</sup> T cell responses.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-11-13
DOI
https://doi.org/10.1126/science.ady5362
Citations
1
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity

Xiaohong Zhao, Peng Wei, Birui Pan, Qiuyan Lan et al.
1 citations
Science
Immunotherapy and Immune Responses
0.80
article

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity

Xiaohong Zhao, Peng Wei, Birui Pan, Qiuyan Lan, Yongzhen Chen, Lei Qin, Ruifeng Li, Kun Wei, Xue Bai, Bowen Yuan, Ling Ni, Zixuan Zhao, Qinli Sun, Wenbo Hu, Chen Dong, Tian Xie, Bowen Xie, Xuan Zhong, Lei Yuan
article en
1 citations

Abstract

Conventional type 1 dendritic cells (cDC1s) capture antigens in peripheral tissues and migrate to draining lymph nodes (dLNs) to prime antigen-specific CD8<sup>+</sup> T cells. How tumor antigens are processed to activate CD8<sup>+</sup> T cell immunity is not well understood. In this work, we show that Ms4a7 is up-regulated in cDC1s after tumor antigen uptake or exposure to exogenous stimuli and is required for their cross-priming ability. Although <i>Ms4a7</i><sup>-/-</sup> mice showed normal cDC1 development and turnover, they failed to prime antigen-specific CD8<sup>+</sup> T cells following infection or tumor development. In human cancers, <i>MS4A7</i> was expressed in a subset of cDC1s, preferentially enriched in dLNs, and correlated with patient survival. Our findings suggest a critical role for Ms4a7 in cDC1-mediated cross-presentation and antitumor CD8<sup>+</sup> T cell responses.

ScienceVol. 390(6774)
Central South University (CN), Westlake University (CN), Third Xiangya Hospital (CN), Center for Life Sciences (CN), Tsinghua University (CN)
Openalex Percentile: Top 22%
Immunotherapy and Immune Responses
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.